Published GLP-1 clinical research - including a real-world study published in Advances in Therapy (2025) covering nearly 10,000 patients - documented mean weight loss of 14.1% for semaglutide 2.4 mg and 16.5% for tirzepatide over one year
Voigt, R
Thats where peptide therapy comes into play, offering innovative solutions for fat-burning and appetite control
Comparable brand drugs including Mounjaro, Zepbound, and Rybelsus remain under brand-name sale in Canada
Heydarpour F, Hemati N, Hadi A, Moradi S, Mohammadi E, Farzaei MH
MC4R receptors are expressed in the hypothalamus, which houses the body's master clock (suprachiasmatic nucleus) and regulates sleep-wake transitions